NCT06748820 E-CANE: a National Program of Remote Health Education Workshops
| NCT ID | NCT06748820 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 48 participants in total. It began in 2025-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
About 2000 adolescents and young adults (AYA) are diagnosed with cancer each year in France. This period of life is marked by a maturation and transition phase in various areas (psychological, physical, sexual, socio-professional...). Cancer occurrence has a very particular impact. AYAs diagnosed and treated for cancer have specific medical and psychosocial needs.In response to these specific needs, Therapeutic Education (TPE), initially developed for patients with chronic disease to help them acquire and maintain skills needed to better manage their daily lives with the constraints of their disease and its treatments, has now its place in cancerology. It has been shown to promote patient independence, improve therapeutic adherence (which is particularly poor in adolescents with cancer), and strengthen the therapeutic alliance between patients and their healthcare team. The strengthening of adolescents's self-care and adaptation skills is also recognized as essential during the experience of an oncological disease. In addition, over the past few years, in the context of the increasing use of the internet and digital technologies, particularly in the daily lives of young people, the implementation of remote TPE sessions (e-TPEs) has developed significantly. In cancerology, digital health interventions have the potential to expand access to the support available to youth with cancer. E-health offers flexibility to the delivery of psychosocial care and could help strengthen youth engagement and enable them to interact with professionals and other young people in a reassuring digital context.This project aims to demonstrate the feasibility of conducting remote health education workshops (e-TPE) for AYAs with cancer, regardless of their place of care in French territory. Following an educational assessment conducted by a professional trained in TPE, three digitalized workshops from the DYNAMO program, will be offered. The adherence to this type of educational interventions, the satisfaction of the patients and the professionals involved, but also the obstacles and difficulties encountered will be analyzed. Demonstrating the feasibility of these e-workshops would allow the spread and the enrichment of this type of interventions. This could facilitate their accessibility for all AYAs in French territory. At the end of this experiment, a randomized study could provide scientific evidence that the development of such a program is a relevant strategy to help young people with cancer manage the challenges associated with their diagnosis and treatment.
Eligibility Criteria
Inclusion Criteria: * Patient with cancer diagnosed for at least one month. * Patient followed by an AYA Coordinating Nurse in one of the 27 French AYA centres. * Patient with Life expectancy ≥ 6 months. * Patient ealth status consistent with program requirements. * Karnosky index \> 60%. * Patient who agrees to participate in the program and benefits from social security. * Patient able to understand, speak and read French. * Patient with no major cognitive impairment (assessed by the patient's referees). * Patient with no sensory disability. * Patient with access to a computer tool (smartphone, tablet, computer) and a WiFi or 4G network. * Non opposition from patient or their legal representative collected. * Patient who has signed the Privacy Policy. * Patient who consented to participate in PTE program. Exclusion Criteria: * Patient unable to use informatic tools. * Known superior cognitive function disorders. * Progressive psychiatric pathology * Drug user or alcohol abuse
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06748820 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 25 Years, studying Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06748820 currently recruiting?
Yes, NCT06748820 is actively recruiting participants. Contact the research team at poiree.m@chu-nice.fr for enrollment information.
Where is the NCT06748820 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT06748820 clinical trial?
NCT06748820 is sponsored by Centre Hospitalier Universitaire de Nice. The trial plans to enroll 48 participants.